Please provide your email address to receive an email when new articles are posted on . Pegcetacoplan reduced proteinuria in patients with rare complement-mediated glomerular diseases vs. placebo.

As 2026 begins, XRP ETFs have delivered the most compelling institutional adoption story in crypto—yet price hasn’t followed. In just 50 days since launching mid-November 2025, these products absorbed ...

XRP ETFs pulled in $483M during December while Bitcoin ETFs lost $1.09B and Ethereum shed $564M. XRP spot price fell 15% to $1.77 despite institutional inflows. Retail selling dominated while ...

US spot crypto ETFs recorded a combined $669 million in net inflows on the first trading day of 2026, signaling a sharp reversal from late-year outflows. Bitcoin products dominated the session with ...

This was supposed to be crypto's year. President Trump got elected vowing to make the U.S. "the crypto capital of the world" — and by many measures, he delivered. From the crypto-friendly regulators ...

BlackRock further separated itself from competitors in the crypto ETF market in 2025, with its Bitcoin and Ether funds, IBIT and ETHA, accounting for the majority of net inflows. US investors poured ...

New Year's Eve opens, with Ripple burning $21,804,950 in its own stablecoin, Bitcoin price prediction pointing to $100,000 for January and Bitwise putting Zcash on ETF watch as 2026 starts, with eyes ...

Bitcoin and Ethereum ETFs continued generating inflows this year. Access broadened to products tracking XRP, Solana, and beyond. The SEC focused on listing standards and staking. This year, ...